Results 11 to 20 of about 118,580 (161)

Pathological conditions associated with rhinitis medicamentosa [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2004
Rhinitis medicamentosa (nose-drop-nose") is a term used for pathological condition of the nasal mucous membrane that results from long-term abuse with intranasal vasoconstrictors.
Milošević Dušanka, Janošević Ljiljana B., Dergenc Ranko, Vasić Milan   +3 more
doaj   +2 more sources

Rhinitis medicamentosa – preventable disease [PDF]

Медицинский совет, 2019
Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa.
A. I. Kryukov, A. B. Turovskiy, I. G. Kolbanova, K. M. Musayev, A. B. Karasov   +4 more
doaj   +2 more sources

Allergic rhinitis: current assessment of medical and social aspects and methods of treatment. intranasal corticosteroids in the treatment of rhinitis [PDF]

Медицинский совет, 2018
The article presents the issues of epidemiology, pathogenesis and treatment of allergic rhinitis. It describes the various types of nonallergic rhinitis, the relationship of allergic rhinitis and rhinosinusitis polyposa, eosinophilic nonallergic rhinitis,
S. V. Tsarev
doaj   +2 more sources

Classification of Nonallergic Rhinitis Syndromes With a Focus on Vasomotor Rhinitis, Proposed to be Known henceforth as Nonallergic Rhinopathy

World Allergy Organization Journal, 2009
Many patients have nasal syndromes that are nonallergic and noninfectious and not caused by mechanical or anatomic abnormalities. There are at least 8 recognized nonallergic rhinitis syndromes: drug-induced rhinitis including rhinitis medicamentosa ...
Michael A. Kaliner, MD
doaj   +2 more sources

Predisposing factors of rhinitis medicamentosa: what can influence drug discontinuation? [PDF]

Rhinology, 2020
BACKGROUND the primary end point of our study was to define risk factors and identify the underlying conditions that may have led to the abuse of vasoconstrictors in rhinitis medicamentosa.
E. de Corso, Rodolfo Francesco Mastrapasqua, L. Tricarico, S. Settimi, T. Di Cesare, D. Mele, L. Trozzi, Giampiero Salonna, G. Paludetti, J. Galli   +9 more
semanticscholar   +2 more sources

Pharmacovigilance analysis of drug-induced hypertrophic rhinitis using FAERS data [PDF]

Scientific Reports
Our study aims to evaluate the risk of drug-induced hypertrophic rhinitis and analyze its epidemiological characteristics utilizing real-world data.
Yan He, Xinzhou Yan, Long Chen, Zhiqiang Lin   +3 more
doaj   +2 more sources

Conservative treatment of chemical injury to the nasal mucosa

Медицинский совет, 2013
The article tells about the ways to increase effectiveness of conservative treatment of rhinitis medicamentosa. 112 patients with a long-term history of use of decongestants were observed.
N. L. Kunelskaya, G. Y. Tsarapkin, M. E. Artemyev, M. Yu. Polyaeva, E. V. Gorovaya   +4 more
doaj   +2 more sources

Radiofrequency Ablation of Inferior Turbinates With Posterior Nasal Nerve Neurolysis for Refractory Rhinitis Medicamentosa

Ear, Nose and Throat Journal
OBJECTIVE To explore the effectiveness of surgical intervention in treating refractory rhinitis medicamentosa (RM) and determine whether laser posterior nasal neurolysis improves outcomes.
Chien-Yu Huang, Yi-Li Hwang
exaly   +2 more sources

Drug-induced rhinitis as a complication of using mucosal decongestants [PDF]

Journal of Education, Health and Sport
Rhinitis medicamentosa is induced by the overuse of topical nasal decongestants. It is characterized by chronic nasal obstruction, not related to allergy or common cold.
Zuzanna Kalinowska, Weronika Matera, Maciej Krężel, Olga Snoch   +3 more
doaj   +2 more sources

Part 1 - imidazolines and the changing face of nasal decongestants [PDF]

Frontiers in Pharmacology
Imidazolines are sympathomimetic drugs used to treat a range of conditions including nasal congestion, ocular disorders, and hypertension. Imidazolines were discovered over 150 years ago.
Rebecca J. Stinson, Laura R. Sadofsky
doaj   +2 more sources